Showing 1 to 10 of 1,809
| Title | Reference number | Reference number sort | Published | Published date sort | Last updated | Last updated sort |
|---|---|---|---|---|---|---|
| Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer | Reference number:TA569 | TA00569 | Published:March 2019 | 20190301 | Last updated:March 2019 | 20190320 |
| Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal) | Reference number:TA570 | TA00570 | Published:March 2019 | 20190301 | Last updated:March 2019 | 20190320 |
| Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib | Reference number:TA571 | TA00571 | Published:March 2019 | 20190301 | Last updated:March 2019 | 20190320 |
| Kendall DL for ECG monitoring in people having cardiac surgery | Reference number:MIB177 | MIB00177 | Published:March 2019 | 20190301 | Last updated:March 2019 | 20190318 |
| Delirium: prevention, diagnosis and management | Reference number:CG103 | CG00103 | Published:July 2010 | 20100701 | Last updated:March 2019 | 20190314 |
| Radially emitting laser fibre treatment of an anal fistula | Reference number:IPG644 | IPG00644 | Published:March 2019 | 20190301 | Last updated:March 2019 | 20190313 |
| Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies | Reference number:TA567 | TA00567 | Published:March 2019 | 20190301 | Last updated:March 2019 | 20190313 |
| Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal) | Reference number:TA568 | TA00568 | Published:March 2019 | 20190301 | Last updated:March 2019 | 20190313 |
| Cochlear implants for children and adults with severe to profound deafness | Reference number:TA566 | TA00566 | Published:March 2019 | 20190301 | Last updated:March 2019 | 20190307 |
| IQoro for stroke-related dysphagia | Reference number:MIB175 | MIB00175 | Published:March 2019 | 20190301 | Last updated:March 2019 | 20190306 |